143 related articles for article (PubMed ID: 33838126)
1. Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3/Akt pathway.
Xing Q; Feng J; Zhang X
Exp Cell Res; 2021 Jun; 403(1):112595. PubMed ID: 33838126
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone suppresses osteogenesis of osteoblast
Pan JM; Wu LG; Cai JW; Wu LT; Liang M
J Recept Signal Transduct Res; 2019 Feb; 39(1):80-86. PubMed ID: 31210570
[TBL] [Abstract][Full Text] [Related]
3. Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways.
Zhao R; Tao L; Qiu S; Shen L; Tian Y; Gong Z; Tao ZB; Zhu Y
Life Sci; 2020 Sep; 257():118044. PubMed ID: 32622944
[TBL] [Abstract][Full Text] [Related]
4. Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast differentiation and ameliorates glucocorticoid-induced bone loss.
Shen GY; Ren H; Shang Q; Zhao WH; Zhang ZD; Yu X; Huang JJ; Tang JJ; Yang ZD; Liang D; Jiang XB
Int J Biol Sci; 2019; 15(10):2182-2197. PubMed ID: 31592234
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin 3A promotes the osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells in inflammatory environments by suppressing the Wnt/β-catenin signaling pathway.
Sun Z; Yan K; Liu S; Yu X; Xu J; Liu J; Li S
J Mol Histol; 2021 Dec; 52(6):1245-1255. PubMed ID: 33566267
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway.
Deng S; Dai G; Chen S; Nie Z; Zhou J; Fang H; Peng H
Biomed Pharmacother; 2019 Feb; 110():602-608. PubMed ID: 30537677
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.
Ma X; Zhang X; Jia Y; Zu S; Han S; Xiao D; Sun H; Wang Y
Int Orthop; 2013 Jul; 37(7):1399-404. PubMed ID: 23645083
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A
Mediero A; Wilder T; Shah L; Cronstein BN
FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
[TBL] [Abstract][Full Text] [Related]
9. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
Li H; Li T; Fan J; Li T; Fan L; Wang S; Weng X; Han Q; Zhao RC
Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids impair bone formation of bone marrow stromal stem cells by reciprocally regulating microRNA-34a-5p.
Kang H; Chen H; Huang P; Qi J; Qian N; Deng L; Guo L
Osteoporos Int; 2016 Apr; 27(4):1493-1505. PubMed ID: 26556739
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner.
Smith E; Frenkel B
J Biol Chem; 2005 Jan; 280(3):2388-94. PubMed ID: 15537647
[TBL] [Abstract][Full Text] [Related]
12. Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A.
Lotz EM; Berger MB; Boyan BD; Schwartz Z
Bone; 2020 May; 134():115260. PubMed ID: 32028017
[TBL] [Abstract][Full Text] [Related]
13. microRNA-199a counteracts glucocorticoid inhibition of bone marrow mesenchymal stem cell osteogenic differentiation through regulation of Klotho expression in vitro.
Tang J; Yu H; Wang Y; Duan G; Wang B; Li W; Zhu Z
Cell Biol Int; 2020 Dec; 44(12):2532-2540. PubMed ID: 32869899
[TBL] [Abstract][Full Text] [Related]
14. Ebselen rescues oxidative-stress-suppressed osteogenic differentiation of bone-marrow-derived mesenchymal stem cells via an antioxidant effect and the PI3K/Akt pathway.
Li Y; Chen G; He Y; Zhang X; Zeng B; Wang C; Yi C; Yu D
J Trace Elem Med Biol; 2019 Sep; 55():64-70. PubMed ID: 31345368
[TBL] [Abstract][Full Text] [Related]
15. The epithelial sodium channel is involved in dexamethasone-induced osteoblast differentiation and mineralization.
Lu L; Wu L; Jia H; Li Y; Chen J; Xu D; Li Q
Cell Biol Toxicol; 2012 Oct; 28(5):279-89. PubMed ID: 22752439
[TBL] [Abstract][Full Text] [Related]
16. Phloretin Suppresses Bone Morphogenetic Protein-2-Induced Osteoblastogenesis and Mineralization via Inhibition of Phosphatidylinositol 3-kinases/Akt Pathway.
Takeno A; Kanazawa I; Tanaka KI; Notsu M; Sugimoto T
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137461
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein D alleviates glucocorticoid-induced osteogenesis suppression in bone marrow mesenchymal stem cells via the PI3K/Akt pathway.
Yu RH; Zhang XY; Xu W; Li ZK; Zhu XD
J Orthop Surg Res; 2020 Aug; 15(1):307. PubMed ID: 32771037
[TBL] [Abstract][Full Text] [Related]
18. Cornuside I promoted osteogenic differentiation of bone mesenchymal stem cells through PI3K/Akt signaling pathway.
Gao F; Xia SL; Wang XH; Zhou XX; Wang J
J Orthop Surg Res; 2021 Jun; 16(1):397. PubMed ID: 34154621
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C/EBPalpha promoter methylation.
Li J; Zhang N; Huang X; Xu J; Fernandes JC; Dai K; Zhang X
Cell Death Dis; 2013 Oct; 4(10):e832. PubMed ID: 24091675
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving β-catenin.
Wu X; Li S; Xue P; Li Y
Exp Cell Res; 2017 Nov; 360(2):281-291. PubMed ID: 28919123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
